Gentherm (THRM) 10-Q 7 May 20 2020 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2020	May 04, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Trading Symbol	THRM
Entity Registrant Name	GENTHERM INCORPORATED
Entity Central Index Key	0000903129
Entity Current Reporting Status	Yes
Current Fiscal Year End Date	--12-31
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		32,599,412
Entity Shell Company	false
Entity File Number	0-21810
Entity Tax Identification Number	95-4318554
Entity Address, Address Line One	21680 Haggerty Road
Entity Address, City or Town	Northville
Entity Address, State or Province	MI
Entity Address, Postal Zip Code	48167
City Area Code	248
Local Phone Number	504-0500
Entity Interactive Data Current	Yes
Entity Incorporation, State or Country Code	MI
Document Quarterly Report	true
Security Exchange Name	NASDAQ
Title of 12(b) Security	Common Stock, no par value
Document Transition Report	false

Consolidated Condensed Balance

Consolidated Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Current Assets:
Cash and cash equivalents	$ 222,939	$ 50,443
Restricted cash	2,505	2,505
Accounts receivable, less allowance of $1,639 and $1,193, respectively	159,011	159,710
Inventory:
Raw materials	60,844	61,323
Work in process	6,778	7,444
Finished goods	50,019	49,712
Inventory, net	117,641	118,479
Other current assets	44,941	42,726
Total current assets	547,037	373,863
Property and equipment, net	152,120	160,605
Goodwill	63,894	64,572
Other intangible assets, net	50,062	49,783
Operating lease right-of-use assets	14,991	11,587
Deferred income tax assets	56,032	57,650
Other non-current assets	9,234	9,326
Total assets	893,370	727,386
Current Liabilities:
Accounts payable	97,065	83,035
Current lease liabilities	4,735	4,586
Current maturities of long-term debt	2,500	2,500
Other current liabilities	67,000	66,583
Total current liabilities	171,300	156,704
Long-term debt, less current maturities	231,667	78,124
Pension benefit obligation	7,619	8,057
Non-current lease liabilities	10,869	6,751
Other non-current liabilities	1,534	5,100
Total liabilities	422,989	254,736
Common Stock:
No par value; 55,000,000 shares authorized, 32,598,854 and 32,674,354 issued and outstanding at March 31, 2020 and December 31, 2019, respectively	102,059	102,507
Paid-in capital	9,648	10,852
Accumulated other comprehensive loss	(54,931)	(42,441)
Accumulated earnings	413,605	401,732
Total shareholders’ equity	470,381	472,650
Total liabilities and shareholders’ equity	$ 893,370	$ 727,386

Consolidated Condensed Balanc_2

Consolidated Condensed Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Statement Of Financial Position [Abstract]
Accounts receivable, allowance	$ 1,639	$ 1,193
Common Stock, par value
Common Stock, shares authorized	55,000,000	55,000,000
Common Stock, shares issued	32,598,854	32,674,354
Common Stock, shares outstanding	32,598,854	32,674,354

Consolidated Condensed Statemen

Consolidated Condensed Statements of Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Product revenues	$ 228,613	$ 257,921
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Cost of sales	$ 162,546	$ 182,614
Gross margin	66,067	75,307
Operating expenses:
Net research and development expenses	17,760	18,897
Selling, general and administrative expenses	25,840	32,651
Restructuring expenses	3,766	1,914
Total operating expenses	47,366	53,462
Operating income	18,701	21,845
Interest expense, net	(748)	(1,368)
Foreign currency (loss) gain	(938)	203
Gain on sale of business		4,970
Impairment loss		(10,484)
Other income	264	143
Earnings before income tax	17,279	15,309
Income tax expense	5,406	6,895
Net income	$ 11,873	$ 8,414
Basic earnings per share	$ 0.36	$ 0.25
Diluted earnings per share	$ 0.36	$ 0.25
Weighted average number of shares – basic	32,692,895	33,573,411
Weighted average number of shares – diluted	32,869,149	33,733,335

Consolidated Condensed Statem_2

Consolidated Condensed Statements of Comprehensive (Loss) Income - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement Of Income And Comprehensive Income [Abstract]
Net income	$ 11,873	$ 8,414
Other comprehensive (loss) income:
Foreign currency translation adjustments	(8,740)	(4,251)
Unrealized (loss) gain on foreign currency derivative securities, net of tax	(3,750)	599
Other comprehensive loss, net of tax	(12,490)	(3,652)
Comprehensive (loss) income	$ (617)	$ 4,762

Consolidated Condensed Statem_3

Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Operating Activities:
Net income	$ 11,873	$ 8,414
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	10,406	11,052
Deferred income taxes	721	1,749
Stock based compensation	1,942	1,968
Defined benefit plan expense (income)	85	(617)
Allowance for credit losses	451	229
Loss on sale of property and equipment	119	178
Operating lease expense	1,651	1,333
Impairment loss		10,484
Gain on sale of business		(4,970)
Changes in assets and liabilities:
Accounts receivable	(2,491)	(8,293)
Inventory	(404)	(229)
Other assets	(4,805)	(5,553)
Accounts payable	13,540	(2,079)
Other liabilities	(3,669)	(6,785)
Net cash provided by operating activities	29,419	6,881
Investing Activities:
Proceeds from the sale of property and equipment	34	28
Proceeds from divestiture of business		47,500
Acquisition of intangible assets	(3,141)
Purchases of property and equipment	(3,231)	(5,150)
Net cash (used in) provided by investing activities	(6,338)	42,378
Financing Activities:
Borrowing of debt	169,546	10,428
Repayments of debt	(16,111)	(49,627)
Cash paid for the cancellation of restricted stock	(404)	(376)
Proceeds from the exercise of Common Stock options	5,902	214
Cash paid for the repurchase of Common Stock	(9,092)	(8,040)
Net cash provided by (used in) financing activities	149,841	(47,401)
Foreign currency effect	(426)	(209)
Net increase in cash, cash equivalents and restricted cash	172,496	1,649
Cash, cash equivalents and restricted cash at beginning of period	52,948	39,620
Cash, cash equivalents and restricted cash at end of period	225,444	41,269
Supplemental disclosure of cash flow information:
Cash paid for taxes	3,525	3,466
Cash paid for interest	$ 537	$ 1,252

Consolidated Condensed Statem_4

Consolidated Condensed Statements of Changes In Shareholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	AOCI Attributable to Parent	Retained Earnings
Beginning Balance at Dec. 31, 2018	$ 479,699	$ 140,300	$ 14,934	$ (39,500)	$ 363,965
Beginning Balance (in shares) at Dec. 31, 2018		33,857,000
Cumulative effect of accounting change due to adoption of ASU | ASU 2016-02	261				261
Stock repurchase	(8,040)	$ (8,040)
Stock repurchase (in shares)		(200,000)
Exercise of Common Stock options for cash	214	$ 1,021	(807)
Exercise of Common Stock options for cash (in shares)		13,000
Cancellation of restricted stock	(376)	$ (376)
Cancelation of restricted stock (in shares)		(17,000)
Stock option compensation	386		386
Common Stock issued to Board of Directors and employees	1,581	$ 1,581
Other comprehensive loss	(3,652)			(3,652)
Net income	8,414				8,414
Ending Balance at Mar. 31, 2019	478,487	$ 134,486	14,513	(43,152)	372,640
Ending Balance (in shares) at Mar. 31, 2019		33,653,000
Beginning Balance at Dec. 31, 2019	$ 472,650	$ 102,507	10,852	(42,441)	401,732
Beginning Balance (in shares) at Dec. 31, 2019	32,674,354	32,674,000
Stock repurchase	$ (9,092)	$ (9,092)
Stock repurchase (in shares)		(246,000)
Exercise of Common Stock options for cash	5,902	$ 7,374	(1,472)
Exercise of Common Stock options for cash (in shares)		162,000
Cancellation of restricted stock	(404)	$ (404)
Cancelation of restricted stock (in shares)		(1,000)
Stock option compensation	268		268
Common Stock issued to Board of Directors and employees	1,674	$ 1,674
Commons stock issued to Board of Directors and employees (in shares)		10,000
Other comprehensive loss	(12,490)			(12,490)
Net income	11,873				11,873
Ending Balance at Mar. 31, 2020	$ 470,381	$ 102,059	$ 9,648	$ (54,931)	$ 413,605
Ending Balance (in shares) at Mar. 31, 2020	32,598,854	32,599,000

Overview

Overview	3 Months Ended
	Mar. 31, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Overview	Note 1 – Overview Gentherm Incorporated is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Unless the context otherwise requires, the terms “Gentherm”, “Company”, “we”, “us” and “our” used herein refer to Gentherm Incorporated and its consolidated subsidiaries. Our products provide solutions for automotive passenger climate comfort and convenience, battery thermal management and cell connecting systems, as well as patient temperature management within the health care industry. Our automotive products can be found in the vehicles of nearly all major automotive manufacturers operating in North America and Europe, and several major automotive manufacturers in Asia. The Company operates in locations aligned with its major customers’ product strategies to provide locally enhanced design, integration and production capabilities. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. On February 1, 2019, the Company completed the divestiture of its environmental test equipment business, Cincinnati Sub Zero industrial chamber business (“CSZ-IC”) and on October 1, 2019, the Company completed the divestiture of its remote power generation systems business, Gentherm Global Power Technologies (“GPT”). The Company’s consolidated condensed financial statements herein include the results of CSZ-IC and GPT through their respective dates of divestiture. CSZ-IC and GPT are not subject to discontinued operations classification. On April 1, 2019, Gentherm acquired Stihler Electronic GmbH (“Stihler”), a leading developer and manufacturer of patient and blood temperature management systems. The acquisition was accounted for as a business combination. Basis of Presentation The unaudited consolidated condensed financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations. The information furnished in the consolidated condensed financial statements include all adjustments (consisting of only normal, recurring adjustments), considered necessary to present fairly the results of operations, financial position and cash flows of the Company. These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The operating results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. In preparing these financial statements, management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of uncertainty. We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates, judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.

New Accounting Pronouncements

New Accounting Pronouncements	3 Months Ended
	Mar. 31, 2020
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]
New Accounting Pronouncements	Note 2 – New Accounting Pronouncements Recently Adopted Accounting Pronouncements Expected Credit Losses In June 2016, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets held. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019. The Company adopted ASU 2016-13 as of January 1, 2020 and there was no significant impact on its consolidated condensed financial statements and related disclosures as a result. The Company considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic and determined that the estimate of credit losses was not significantly impacted . Cloud Computing Arrangements That Are Service Contracts In August 2018, the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred and recognized over the term of the arrangement if those costs would be capitalized by the customer in a software licensing arrangement under the internal-use software guidance. ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019. The Company adopted ASU 2018-15 as of January 1, 2020 and there was no significant impact on its consolidated condensed financial statements and related disclosures as a result. Fair Value Measurement In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 removes certain disclosure requirements, including (i) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, (ii) the policy for timing of transfer between levels, and (iii) the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds new disclosure requirements, including (i) the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. The Company adopted ASU 2018-13 as of January 1, 2020 and there was no significant impact on its consolidated condensed financial statements and related disclosures as a result. Recently Issued Accounting Pronouncements Not Yet Adopted Retirement Benefits In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans.” ASU 2018-14 removes certain disclosure requirements, including (i) the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year, and (ii) the amount and timing of plan assets expected to be returned to the employer. ASU 2018-14 also adds new disclosure requirements, including (i) the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates and (ii) an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. ASU 2018-14 is effective for annual periods ending after December 15, 2020. Early adoption of the amendments in this update is permitted. The Company is currently in the process of determining the impact the implementation of ASU 2018-14 will have on the Company’s financial statement note disclosures. Income Taxes In December 2019, the FASB issued Accounting Standard Update ASU No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes". This ASU simplifies the accounting for income taxes by removing certain exceptions previously included in the guidance. In addition, the ASU provides new guidance on accounting for specific taxes and minor codification improvements.

Acquisitions and Divestitures

Acquisitions and Divestitures	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Acquisitions and Divestitures	Note 3 – Acquisitions and Divestitures In June 2018, Gentherm announced a new strategic plan. An important element of the strategy was the elimination of investments in non-core areas, including GPT and CSZ-IC. Divestiture of CSZ-IC On February 1, 2019, the Company completed the sale of CSZ-IC and the former Cincinnati Sub-Zero headquarters facility to Weiss Technik North America, Inc. for total cash proceeds of $47,500, including $2,500 of cash proceeds placed into an escrow account for a period of up to one year as partial security for the Company’s obligations under the sale agreement. The cash proceeds held in escrow are recorded as restricted cash within the consolidated condensed balance sheets. In connection with the sale, Gentherm entered into an operating lease agreement for a portion of the office and manufacturing building space purchased by Weiss Technik North America, Inc. The Company recognized a $4,970 pre-tax gain on the sale of CSZ-IC during the three months ended March 31, 2019, which is classified as Gain on sale of business within the consolidated condensed statements of income. In January 2020, claims were made against the cash proceeds held in the escrow account, which has been maintained in escrow following the expiration of the one-year escrow period. The Company is not able to estimate the possible loss, if any, of amounts held in escrow in connection with this matter. Divestiture of GPT During 2018, the Company determined that GPT met the held for sale criteria. During the three months ended March 31, 2019, the Company continued to assess the fair value of the GPT disposal group, less costs to sell, at each reporting period. As a result of these fair value measurements, the Company recorded impairment loss of Acquisition of Stihler On April 1, 2019, Gentherm acquired Stihler for a purchase price of $15,476, net of cash acquired and including $653 of contingent consideration to be paid upon achievement of a milestone that must be completed by September 2020. In addition, the purchase agreement includes a contingent payment of $653 to be paid if the selling shareholder remains employed by Stihler through December 2020. This amount is being recognized as a component of selling, general and administrative expenses ratably over the service period. The results of operations of Stihler were reported within the Company’s Industrial segment from the date of acquisition. The acquisition was accounted for as a business combination. The purchase price and related allocation were finalized in the fourth quarter of 2019. The pro forma effect of the Stihler acquisition does not materially impact the Company’s reported results for any period presented, and as a result no pro forma financial statements are presented.

Restructuring

Restructuring	3 Months Ended
	Mar. 31, 2020
Restructuring And Related Activities [Abstract]
Restructuring	Note 4 – Restructuring Manufacturing Footprint Rationalization On September 23, 2019, the Company committed to a restructuring plan to improve the Company’s manufacturing productivity and rationalize its footprint. Under this plan, the Company will relocate and consolidate certain existing automotive manufacturing and, as a result, reduce the number of plants by two. On March 20, 2020, the Company announced the initial phase of this restructuring plan, which includes the consolidation of all North American electronics manufacturing to Celaya, Mexico. This will result in the closure of the Burlington, Canada facility, and the transfer of electronics manufacturing from Acuña, Mexico. During the three months ended March 31, 2020, the Company recognized restructuring expense of $248 for employee separation costs and $242 for accelerated depreciation. The Company has recorded approximately $7,440 of restructuring expenses since the inception of this program. The Company expects to incur total costs of between $20,000 and $24,000, of which between $17,000 and $21,000 are expected to be cash expenditures. The total expected costs include employee separation costs of between $9,000 and $11,000, capital expenditures of between $4,500 and $5,500 and non-cash expenses for accelerated depreciation and impairment of fixed assets of approximately $3,000. The Company also expects to incur other transition costs including recruiting, relocation, and machinery and equipment move and set up costs of between $3,500 and $4,500. The actions under this plan are expected to be substantially completed by the end of 2021. The actual timing, costs and savings of the plan may differ materially from the Company’s current expectations and estimates. Other Restructuring Activities As part of the Company’s continued efforts to optimize its cost structure, the Company has undertaken several discrete restructuring actions. During the three months ended March 31, 2020 and 2019, the Company recognized $3,054 and $395 of employee separation costs, respectively, and $222 and $4 of other related costs, respectively. In addition, during the three months ended March 31, 2019, the Company recognized $425 of asset impairment loss. These restructuring expenses were primarily associated with restructuring actions focused on the rotation of our manufacturing footprint to lower cost locations and the reduction of global overhead costs. These discrete restructuring actions are expected to approximate the total cumulative costs for those actions. The Company will continue to explore opportunities to improve its future profitability and competitiveness. These actions may result in the recognition of additional restructuring charges that could be material. GPT and CSZ-IC Costs associated with the divestiture process were classified as restructuring. During the three months ended March 31, 2019, the Company recognized $251 of employee separation costs, and $839 of other related costs, related to the marketing of GPT and CSZ-IC, which were classified as restructuring. The Company has recorded approximately $2,303 of restructuring expenses since inception of this program and it is considered complete. Restructuring Expenses By Reporting Segment The following table summarizes restructuring expense for the three months ended March 31, 2020 and 2019 by reporting segment: Three Months Ended March 31, 2020 2019 Automotive $ 3,122 $ 368 Industrial 96 1,546 Reconciling items 548 — Total $ 3,766 $ 1,914 Restructuring Liability Restructuring liabilities are classified as accrued liabilities on the consolidated condensed balance sheets. The following table summarizes restructuring liability for the three months ended March 31, 2020: Employee Separation Costs Accelerated Depreciation Charges Other Related Costs Total Balance at December 31, 2019 $ 5,994 $ — $ 71 $ 6,065 Additions, charged to restructuring expenses 3,302 242 222 3,766 Cash payments (1,932 ) — (202 ) (2,134 ) Non-cash utilization — (242 ) — (242 ) Currency translation (306 ) — 38 (268 ) Balance at March 31, 2020 $ 7,058 $ — $ 129 $ 7,187

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings per Share	Note 5 – Basic earnings per share are computed by dividing net income by the weighted average number of shares of Common Stock outstanding during the period. The Company’s diluted earnings per share give effect to all potential shares of Common Stock outstanding during a period that do not have an anti-dilutive impact to the calculation. In computing the diluted earnings per share, the treasury stock method is used in determining the number of shares assumed to be issued from the exercise of Common Stock equivalents. The following table illustrates earnings per share and the weighted average shares outstanding used in calculating basic and diluted earnings per share: Three Months Ended March 31, 2020 2019 Net income $ 11,873 $ 8,414 Basic weighted average shares of Common Stock outstanding 32,692,895 33,573,411 Dilutive effect of stock options, restricted stock awards and restricted stock units 176,254 159,924 Diluted weighted average shares of Common Stock outstanding 32,869,149 33,733,335 Basic earnings per share $ 0.36 $ 0.25 Diluted earnings per share $ 0.36 $ 0.25 The following table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive. Three Months Ended March 31, 2020 2019 Anti-dilutive securities share impact 682,741 396,500

Segment Reporting

Segment Reporting	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Reporting	Note 6 – Segment Reporting Segment information is used by management for making strategic operating decisions for the Company. Management evaluates the performance of the Company’s segments based primarily on operating income or loss. The Company’s reportable segments are as follows: • Automotive – this segment represents the design, development, manufacturing and sales of automotive climate comfort systems, specialized automotive cable systems, battery thermal management, and automotive electronic systems. • Industrial – this segment represents the combined results from our patient temperature management systems business (“Medical”) , GPT (through October 1, 2019), CSZ-IC (through February 1, 2019) and Gentherm’s advanced research and development division. The operating results from these businesses and division are presented together as one reporting segment because of their historical joint concentration on identifying new markets and product applications based on thermal management technologies. • Reconciling Items – includes corporate selling, general and administrative costs and acquisition transaction costs. The tables below present segment information about the reported product revenues, depreciation and amortization and operating income (loss) of the Company for three months ended March 31, 2020 and 2019. Three Months Ended March 31, Automotive Industrial Reconciling Items Consolidated Total 2020: Product revenues $ 216,472 $ 12,141 $ — $ 228,613 Depreciation and amortization 9,524 507 375 10,406 Operating income (loss) 31,706 (605 ) (12,400 ) 18,701 2019: Product revenues $ 242,357 $ 15,564 $ — $ 257,921 Depreciation and amortization 10,296 290 466 11,052 Operating income (loss) 39,896 (4,514 ) (13,537 ) 21,845 Automotive and Industrial segment product revenues by product category for the three months ended March 31, 2020 and 2019 were as follows: Three Months Ended March 31, 2020 2019 Climate Control Seats (CCS) $ 82,528 $ 94,354 Seat Heaters 64,532 73,920 Automotive Cables 22,140 23,749 Steering Wheel Heaters 19,235 16,970 Battery Thermal Management (BTM) 11,209 10,745 Electronics 10,376 12,852 Other Automotive 6,452 9,767 Subtotal Automotive 216,472 242,357 Medical 12,141 8,187 GPT — 3,959 CSZ-IC — 3,418 Subtotal Industrial 12,141 15,564 Total Company $ 228,613 $ 257,921 Total product revenues information by geographic area is as follows (based on shipment destination): Three Months Ended March 31, 2020 2019 United States $ 105,918 $ 118,454 Germany 16,830 23,210 South Korea 16,417 14,978 Japan 16,137 18,591 China 13,003 15,597 Czech Republic 10,073 12,142 Canada 8,262 10,291 Romania 7,659 6,922 United Kingdom 6,964 8,832 Other 27,350 28,904 Total Non-U.S. $ 122,695 $ 139,467 Total Company $ 228,613 $ 257,921

Revenue Recognition

Revenue Recognition	3 Months Ended
	Mar. 31, 2020
Revenue Recognition And Deferred Revenue [Abstract]
Revenue Recognition	Note 7 – Revenue Recognition Contract Balances The Company has no material contract assets. The Company’s contract liabilities are comprised of material rights in the Automotive segment. The aggregate amount of transaction price allocated to material rights that remained unsatisfied as of March 31, 2020 was $186. The Company expects to recognize into revenue, 23% of this unearned revenue balance during the remainder of 2020, and the remaining 28%, 27% and 22% in 2021, 2022 and 2023, respectively. Changes in the unearned revenue balance during the three months ended March 31, 2020 were as follows: Balance as of December 31, 2019 $ 579 Additions to unearned revenue — Reclassified to revenue (389 ) Currency impacts (4 ) Balance as of March 31, 2020 $ 186 Assets Recognized from the Costs to Obtain a Contract with a Customer The Company recognizes an asset for the incremental costs of obtaining a contract with a customer if the benefits of those costs are expected to be realized for a period greater than one year. Total capitalized costs to obtain a contract were $1,800 and $1,893 as of March 31, 2020 and December 31, 2019, respectively. These amounts are recorded in other current assets and are being amortized into product revenues over the expected production life of the program.

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Income Taxes	Note 8 – Income Taxes At the end of each interim period, the Company makes its best estimate of the annual expected effective income tax rate and applies that rate to its ordinary year-to-date earnings or loss. The income tax provision or benefit related to unusual or infrequent items, if applicable, that will be separately reported or reported net of their related tax effects are individually computed and recognized in the interim period in which those items occur. In addition, the effect of changes in enacted tax laws or rates, tax status, judgment on the realizability of a beginning-of-the-year deferred tax asset in future years or income tax contingencies is recognized in the interim period in which the change occurs. The computation of the annual expected effective income tax rate at each interim period requires certain estimates and assumptions including, but not limited to, the expected pre-tax income (or loss) for the year, projections of the proportion of income (and/or loss) earned and taxed in respective jurisdictions, permanent and temporary differences, and the likelihood of the realizability of deferred tax assets generated in the current year. Jurisdictions with a projected loss for the year or a year-to-date loss for which no tax benefit or expense can be recognized due to a valuation allowance are excluded from the estimated annual effective tax rate. The impact of such an exclusion could result in a higher or lower effective tax rate during a particular quarter, based upon the composition and timing of actual earnings compared to annual projections. The estimates used to compute the provision or benefit for income taxes may change as new events occur, additional information is obtained or as our tax environment changes. To the extent that the expected annual effective income tax rate changes, the effect of the change on prior interim periods is included in the income tax provision in the period in which the change in estimate occurs. On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into U.S. law. The CARES Act provides a stimulus and assistance package intended to address the impact of the COVID-19 pandemic, including tax relief and government loans, grants and investments. As permitted by the CARES Act, the Company expects to defer the payment of payroll taxes each quarter for the remainder of 2020 to be paid in the fourth quarters of 2021 and 2022. A summary of the provision for income taxes and the corresponding effective tax rate for the three months ended March 31, 2020 and 2019, is shown below: Three Months Ended March 31, 2020 2019 Income tax expense $ 5,406 $ 6,895 Earnings before income tax $ 17,279 $ 15,309 Effective tax rate 31.3 % 45.0 % Income tax expense $ 5,406 $ 6,895 Earnings before income tax excluding impairment loss $ 17,279 $ 25,793 Effective tax rate excluding impairment loss 31.3 % 26.7 % For the three months ended March 31, 2019, the Company recognized a loss of $10,484 related to a non-deductible impairment loss. The annual effective tax rates differ from the U.S. statutory rate primarily due to foreign rates which differ from those in the U.S., U.S. taxes on foreign earnings, the realization of certain business tax credits, including research and development and foreign tax credits, and the applicable withholding taxes on the projected future repatriations of the earnings from the Company’s non-U.S. operations that are not considered permanently reinvested.

Details of Certain Balance Shee

Details of Certain Balance Sheet Components	3 Months Ended
	Mar. 31, 2020
Balance Sheet Components [Abstract]
Details of Certain Balance Sheet Components	Note 9 – Details of Certain Balance Sheet Components March 31, 2020 December 31, 2019 Other current assets: Income tax and other tax receivable $ 16,648 $ 17,057 Notes receivable 9,308 9,963 Prepaid expenses 9,027 7,022 Billable tooling 5,471 5,194 Short-term derivative financial instruments — 1,242 Other 4,487 2,248 Total other current assets $ 44,941 $ 42,726 Other current liabilities: Liabilities from discounts and rebates $ 18,877 $ 16,593 Accrued employee liabilities 16,150 26,019 Restructuring 7,187 6,065 Income and other taxes payable 5,644 3,693 Derivative financial instruments 3,553 — Accrued warranty 3,323 4,596 Other 12,266 9,617 Total other current liabilities $ 67,000 $ 66,583

Goodwill and Other Intangibles

Goodwill and Other Intangibles	3 Months Ended
	Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangibles	Note 10 – Goodwill and Other Intangibles Goodwill A summary of changes in the carrying amount of goodwill, by operating segment, for the three months ended March 31, 2020 is as follows: Automotive Industrial Total Balance as of December 31, 2019 $ 36,938 $ 27,634 $ 64,572 Exchange rate impact (502 ) (176 ) (678 ) Balance as of March 31, 2020 $ 36,436 $ 27,458 $ 63,894 Other Intangible Assets Other intangible assets and accumulated amortization balances as of March 31, 2020 and December 31, 2019 were as follows: Gross Carrying Value Accumulated Amortization Net Carrying Value Definite-lived: Customer relationships $ 87,519 $ (51,181 ) $ 36,338 Technology 27,782 (19,943 ) 7,839 Product development costs 19,455 (18,240 ) 1,215 Indefinite-lived: Tradenames 4,670 — 4,670 Balance as of March 31, 2020 $ 139,426 $ (89,364 ) $ 50,062 Gross Carrying Value Accumulated Amortization Net Carrying Value Definite-lived: Customer relationships $ 89,208 $ (50,687 ) $ 38,521 Technology 25,106 (19,866 ) 5,240 Product development costs 19,911 (18,559 ) 1,352 Indefinite-lived: Tradenames 4,670 — 4,670 Balance as of December 31, 2019 $ 138,895 $ (89,112 ) $ 49,783 On February 28, 2020, Gentherm acquired the automotive patents and technology of a development-stage technology company for $3,141. The investment was accounted for as an asset acquisition of defensive intangible assets and will be amortized over 6 years.

Debt

Debt	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Debt	Note 11 – Debt The following table summarizes the Company’s debt as of March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 Interest Rate Principal Balance Interest Rate Principal Balance Amended Credit Agreement: U.S. Revolving Note (U.S. Dollar Denominations) 2.20 % $ 183,000 3.05 % $ 50,000 U.S. Revolving Note (Euro Denominations) 1.25 % 42,417 1.25 % 21,874 DEG Vietnam Loan 5.21 % 8,750 5.21 % 8,750 Total debt 234,167 80,624 Less: current maturities (2,500 ) (2,500 ) Long-term debt, less current maturities $ 231,667 $ 78,124 Amended Credit Agreement As of December 31, 2018, the Company, together with certain direct and indirect subsidiaries, had a credit agreement (the “Credit Agreement”) which included a revolving credit note (“U.S. Revolving Note”) with a maximum borrowing capacity of $350,000. On June 27, 2019, the Company entered into an Amended and Restated Credit Agreement (the “Amended Credit Agreement”) with a consortium of lenders and Bank of America, N.A. as administrative agent. The Amended Credit Agreement amended and restated in its entirety the Credit Agreement. The outstanding principal and interest of the U.S. Revolving Note under the Credit Agreement continued and constitute obligations under the Amended Credit Agreement. The Amended Credit Agreement increased the U.S. Revolving Note from $350,000 to $475,000 and extended the maturity from March 17, 2021 to June 27, 2024. Subject to specified conditions, the Company can increase the U.S. Revolving Note or incur secured term loans in an aggregate amount of $175,000. The Amended Credit Agreement also provides $15,000 availability for the issuance of letters of credit and a maximum of $40,000 for swing line borrowing. Any amount of the facility utilized for letters of credit or swing line loans outstanding will reduce the amount available under the Amended Credit Agreement. The Company had no outstanding letters of credit issued under the Amended Credit Agreement as of March 31, 2020 and December 31, 2019. The U.S. borrowers and guarantors participating in the Amended Credit Agreement have entered into a related amended and restated pledge and security agreement. The amended and restated pledge and security agreement grants a security interest to the lenders in substantially all of the personal property of the Company and its U.S. subsidiaries designated as borrowers to secure their respective obligations under the Amended Credit Agreement, including the stock and membership interests of specified subsidiaries (limited to 66% of the stock in the case of certain non-U.S. subsidiaries). In addition to the security obligations, all obligations under the Amended Credit Agreement are unconditionally guaranteed by certain of the Company’s subsidiaries. The Amended Credit Agreement restricts, among other things, the amount of dividend payments the Company can make to shareholders. The Amended Credit Agreement contains covenants, that, among other things, (i) prohibit or limit the ability of the borrowers and any material subsidiary to incur additional indebtedness, create liens, pay dividends, make certain types of investments (including acquisitions), enter into certain types of transactions with affiliates, prepay other indebtedness, sell assets, merge with other companies or enter into certain other transactions outside the ordinary course of business, and (ii) require that Gentherm maintain a minimum Consolidated Interest Coverage Ratio and Consolidated Leverage Ratio (based on consolidated EBITDA for the applicable trailing 12-month period as defined in the Amended Credit Agreement) as of the end of any fiscal quarter. The Amended Credit Agreement also contains customary events of default. Under the Amended Credit Agreement, U.S. Dollar denominated loans bear interest at either a base rate (“Base Rate Loans”) or Eurocurrency rate (“Eurocurrency Rate Loans”), plus a margin (“Applicable Rate”). The rate for Base Rate Loans is equal to the highest of the Federal Funds Rate (0.08% at March 31, 2020) plus 0.50%, Bank of America’s prime rate (3.25% at March 31, 2020), or the Eurocurrency rate plus 1.00%. The rate for Eurocurrency Rate Loans denominated in U.S. Dollars is equal to the London Interbank Offered Rate (0.99% at March 31, 2020). All loans denominated in a currency other than the U.S. Dollar must be Eurocurrency Rate Loans. Interest is payable at least quarterly. The Applicable Rate varies based on the Consolidated Leverage Ratio reported by the Company. As long as the Company is not in default of the terms and conditions of the Amended Credit Agreement, the lowest and highest possible Applicable Rate is 1.25% and 2.25%, respectively, for Eurocurrency Rate Loans and 0.25% and 1.25%, respectively, for Base Rate Loans. In March 2020, the Company increased its borrowings under the Amended Credit Agreement by $169,546 as a safeguard to increase its cash position and provide additional financial flexibility due to the COVID-19 pandemic. The proceeds will be used for working capital and for other general corporate purposes permitted by the Amended Credit Agreement. As of March 31, 2020, inclusive of the new borrowings, $225,417 was outstanding under the $226,743 remains available for additional borrowings under the subject to specified conditions that Gentherm currently satisfies DEG Vietnam Loan The Company also has a fixed interest rate loan with the German Investment Corporation (“DEG”), a subsidiary of KfW Banking Group, a Germany government-owned development bank. The fixed interest rate senior loan agreement with DEG was used to finance the construction and set up of the Vietnam production facility (“DEG Vietnam Loan”). The DEG Vietnam Loan is subject to semi-annual principal payments that began November 2017 and will end May 2023. Under the terms of the DEG Vietnam Loan, the Company must maintain a minimum Equity Ratio and Enhanced Equity Ratio, as defined by the DEG Vietnam Loan agreement, based on the financial statements of Gentherm’s wholly owned subsidiary, Gentherm Vietnam Co. Ltd. As of March 31, 2020, the Company was in compliance with the terms of the Amended Credit Agreement and DEG Vietnam Loan. The scheduled principal maturities of our debt as of March 31, 2020 were as follows: Year U.S. Revolving Note DEG Vietnam Note Total Remainder of 2020 $ — $ 2,500 $ 2,500 2021 — 2,500 2,500 2022 — 2,500 2,500 2023 — 1,250 1,250 2024 225,417 — 225,417 Total $ 225,417 $ 8,750 $ 234,167

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	Note 12 – Leases The Company has operating leases for office, manufacturing and research and development facilities, as well as land leases for certain manufacturing facilities that are accounted for as operating leases. The Company also has operating leases for office equipment and automobiles. Excluding land leases, our leases have remaining lease terms ranging from less than 1 year to 12 years and may include options to extend the lease for an additional term equal to the original term of the lease. Land leases have remaining lease terms that range from 41 to 43 years and some which specify that the end of the lease term is at the discretion of the lessee. The Company does not have lease arrangements with related parties. Components of lease expense for the three months ended March 31, 2020 were as follows: Three Months Ended March 31, 2020 Lease cost: Operating lease cost $ 1,586 Short-term lease cost 509 Sublease income (40 ) Total lease cost $ 2,055 Other information related to leases is as follows: Three Months Ended March 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 1,621 Right-of-use lease assets obtained in exchange for lease obligations: Operating leases $ 6,349 March 31, 2020 Weighted average remaining lease term: Operating leases 6.5 years Weighted average discount rate: Operating leases 5.08 % A summary of operating leases as of March 31, 2020, under all non-cancellable operating leases with terms exceeding one year is as follows: 2020 (excluding the three months ended March 31, 2020) $ 4,252 2021 4,153 2022 1,997 2023 1,256 2024 1,258 2025 or later 5,468 Total future minimum lease payments 18,384 Less imputed interest (2,780 ) Total $ 15,604

Financial Instruments

Financial Instruments	3 Months Ended
	Mar. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Financial Instruments	Note 13 – Financial Instruments Cash, Cash Equivalents and Restricted Cash The Company has cash that is legally restricted as to use or withdrawal. A reconciliation of cash and cash equivalents on the consolidated condensed balance sheets to cash, cash equivalents and restricted cash presented on the consolidated condensed statements of cash flows is as follows: March 31, 2020 December 31, 2019 Cash and cash equivalents presented in the consolidated condensed balance sheets $ 222,939 $ 50,443 Restricted cash 2,505 2,505 Cash, cash equivalents and restricted cash presented in the consolidated condensed statements of cash flows $ 225,444 $ 52,948 Derivative Financial Instruments The Company is exposed to various market risks including, but not limited to, changes in foreign currency exchange rates, changes in interest rates and commodity price fluctuations. Market risks for changes in interest rates relate primarily to its debt obligations under the Amended Credit Agreement. Foreign currency exchange risks are attributable to sales to foreign customers and purchases from foreign suppliers not denominated in a location’s functional currency, foreign plant operations, intercompany indebtedness, intercompany investments and include exposures to the Euro, Mexican Peso, Canadian Dollar, Hungarian Forint, Macedonian Denar, Ukrainian Hryvnia, Japanese Yen, Chinese Renminbi, Korean Won and Vietnamese Dong. The Company regularly enters into derivative contracts with the objective of managing its financial and operational exposure arising from these risks by offsetting gains and losses on the underlying exposures with gains and losses on the financial instruments used to hedge them. The maximum length of time over which the Company hedges its exposure to foreign currency exchange risks is one year. The Company had foreign currency derivative contracts with a notional value of $22,176 and $14,449 outstanding as of March 31, 2020 and December 31, 2019, respectively. The Company does not enter into derivative financial instruments for speculative or trading purposes. The Company’s hedging relationships are formally documented at the inception of the hedge, and hedges must be highly effective in offsetting changes to future cash flows on hedged transactions both at the inception of a hedge and on an ongoing basis to be designated for hedge accounting treatment. For derivative contracts which can be classified as a cash flow hedge, the effective portion of the change in the fair value of the derivative is recorded to accumulated other comprehensive loss in the consolidated condensed balance sheets. When the underlying hedge transaction is realized, the gain or loss included in accumulated other comprehensive loss is recorded in earnings in the consolidated condensed statements of income on the same line as the gain or loss on the hedged item attributable to the hedged risk. The Company records the ineffective portion of foreign currency hedging instruments, if any, to foreign currency gain (loss) in the consolidated condensed statements of income. The Company uses an income approach to value derivative instruments, analyzing quoted market prices to calculate the forward values and then discounts such forward values to the present value using benchmark rates at commonly quoted intervals for the instrument’s full term. Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of March 31, 2020 is as follows: Asset Derivatives Liability Derivatives Hedge Designation Fair Value Hierarchy Balance Sheet Location Fair Value Balance Sheet Location Fair Value Net Asset/ (Liabilities) Foreign currency derivatives Cash flow hedge Level 2 Other current assets $ — Other current liabilities $ (3,553 ) $ (3,553 ) Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of December 31, 2019 is as follows: Asset Derivatives Liability Derivatives Hedge Designation Fair Value Hierarchy Balance Sheet Location Fair Value Balance Sheet Location Fair Value Net Asset/ (Liabilities) Foreign currency derivatives Cash flow hedge Level 2 Other current assets $ 1,242 Other current liabilities $ — $ 1,242 Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows: Three Months Ended March 31, Location 2020 2019 Foreign currency derivatives Cost of sales $ 78 $ 240 Other comprehensive (loss) income (4,795 ) 766 Foreign currency loss (71 ) (37 ) Total foreign currency derivatives $ (4,788 ) $ 969 The Company did not incur any hedge ineffectiveness during the three months ended March 31, 2020 and 2019.

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 14 – Fair Value Measurements Fair value is defined as the exchange price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Fair value measurements are based on one or more of the following three valuation techniques: Market : This approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities. Income : This approach uses valuation techniques to convert future amounts to a single present value amount based on current market expectations. Cost : This approach is based on the amount that would be required to replace the service capacity of an asset (replacement cost). The Company uses the following fair value hierarchy to measure fair value into three broad levels, which are described below: Level 1 : Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities. The fair value hierarchy gives the highest priority to Level 1 inputs. Level 2 : Inputs, other than quoted market prices included in Level 1, that are observable either directly or indirectly for the asset or liability. Level 3 : Unobservable inputs that are used when little or no market data is available. The fair value hierarchy gives the lowest priority to Level 3 inputs. Items Measured at Fair Value on a Recurring Basis Except for derivative instruments (see Note 13), pension plan assets and a corporate owned life insurance policy, the Company had no material financial assets and liabilities that were carried at fair value at March 31, 2020 and December 31, 2019. In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible and also considers counterparty credit risk in its assessment of fair value. Items Measured at Fair Value on a Nonrecurring Basis The Company measures certain assets and liabilities at fair value on a non-recurring basis. As these nonrecurring fair value measurements are generally determined using unobservable inputs, these fair value measurements are classified within Level 3 of the fair value hierarchy. As of March 31, 2020 and December 31, 2019, there were no additional significant assets or liabilities measured at fair value on a non-recurring basis. Items Not Carried at Fair Value The Company uses an income valuation technique to measure the fair values of its debt instruments by converting amounts of future cash flows to a single present value amount using rates based on current market expectations (Level 2 inputs). As of March 31, 2020, and December 31, 2019, the carrying values of the indebtedness under the Company’s Amended Credit Agreement were not materially different than its estimated fair values because the interest rates on variable rate debt approximated rates currently available to the Company (see Note 11). Discount rates used to measure the fair value of the DEG Vietnam Loan are based on quoted swap rates. As of March 31, 2020, the carrying value of the DEG Vietnam Loan was $8,750 as compared to an estimated fair value of $9,063. As of December 31, 2019, the carrying value of the DEG Vietnam Loan was $8,750 as compared to an estimated fair value of $8,785.

Equity

Equity	3 Months Ended
	Mar. 31, 2020
Stockholders Equity Note [Abstract]
Equity	Note 15 – Equity In December 2016, the Board of Directors of Gentherm Incorporated (“Board of Directors”) authorized a three-year

Reclassifications Out of Accumu

Reclassifications Out of Accumulated Other Comprehensive Loss	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Reclassifications Out of Accumulated Other Comprehensive Income Loss	Note 16 – Reclassifications Out of Accumulated Other Comprehensive Loss Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the three months ended March 31, 2020 and March 31, 2019 were as follows: Defined Benefit Pension Plans Foreign Currency Translation Adjustments Foreign Currency Hedge Derivatives Total Balance at December 31, 2019 $ (3,371 ) $ (39,965 ) $ 895 $ (42,441 ) Other comprehensive loss before reclassifications — (8,687 ) (4,170 ) (12,857 ) Income tax effect of other comprehensive (loss) income before reclassifications — (53 ) 909 856 Amounts reclassified from accumulated other comprehensive loss into net income — — (625 ) a (625 ) Income taxes reclassified into net income — — 136 136 Net current period other comprehensive loss — (8,740 ) (3,750 ) (12,490 ) Balance at March 31, 2020 $ (3,371 ) $ (48,705 ) $ (2,855 ) $ (54,931 ) (a) The amounts reclassified from accumulated other comprehensive income (loss) were included in cost of sales. Defined Benefit Pension Plans Foreign Currency Translation Adjustments Foreign Currency Hedge Derivatives Total Balance at December 31, 2018 $ (2,339 ) $ (37,157 ) $ (4 ) $ (39,500 ) Other comprehensive income (loss) before reclassifications — (4,074 ) 717 (3,357 ) Income tax effect of other comprehensive loss before reclassifications — (177 ) (156 ) (333 ) Amounts reclassified from accumulated other comprehensive loss into net income — — 49 a 49 Income taxes reclassified into net income — — (11 ) (11 ) Net current period other comprehensive (loss) income — (4,251 ) 599 (3,652 ) Balance at March 31, 2019 $ (2,339 ) $ (41,408 ) $ 595 $ (43,152 ) (a) The amounts reclassified from accumulated other comprehensive income (loss) were included in cost of sales. The Company expects all of the existing gains and losses related to foreign currency hedge derivatives reported in accumulated other comprehensive loss as of March 31, 2020 to be reclassified into earnings during the next twelve months. See Note 13 for additional information about derivative financial instruments and the effects from reclassification to net income.

Commitments and Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 17 – Commitments and Contingencies The Company may be subject to various legal actions and claims in the ordinary course of its business, including those arising out of breach of contracts, product warranties, product liability, intellectual property rights, environmental matters, regulatory matters and employment-related matters. The Company establishes accruals for matters which it believes that losses are probable and can be reasonably estimated. Although it is not possible to predict with certainty the outcome of these matters, the Company is of the opinion that the ultimate resolution of these matters will not have a material adverse effect on its consolidated condensed results of operations or financial position. Product liability and warranty reserves are recorded separately from legal reserves, as described below. Product Liability and Warranty Matters The Company accrues warranty obligations for products sold based on management estimates of future failure rates and current claim cost experience, with support from the sales, engineering, quality and legal functions. Using historical information available to the Company, including claims already filed by customers, the warranty accrual is adjusted quarterly to reflect management’s best estimate of future claims. The Company maintains liability insurance coverage at levels based on commercial norms and historical claims experience. The Company can provide no assurances that it will not experience material claims in the future or that it will not incur significant costs to defend such claims. The following is a reconciliation of the changes in accrued warranty costs: Three Months Ended March 31, 2020 2019 Balance at beginning of the period $ 4,596 $ 4,514 Warranty claims paid (1,278 ) (276 ) Warranty expense for products shipped during the period 500 709 Adjustments to warranty estimates from prior periods (450 ) (305 ) Adjustments due to currency translation (45 ) (26 ) Balance at end of period $ 3,323 $ 4,616

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2020
Subsequent Events [Abstract]
Subsequent Events	Note 18 – Subsequent Events Subsequent to March 31, 2020, the impact of the COVID-19 pandemic on our business, results of operations and financial condition has materially worsened as compared to the first quarter of 2020. In particular, the Company significantly reduced production at its manufacturing facilities in response to COVID-19 related government mandates, reduced demand conditions and other operational drivers. This resulted in temporary, partial closures of several of the Company’s manufacturing facilities in the North America and Europe. Meanwhile, certain manufacturing facilities that were closed as of March 31, 2020 have re-opened. The extent of the further impact of the COVID-19 outbreak on the Company’s operational and financial performance, even after business operations resume, will depend on certain developments, including the duration and spread of the outbreak, the impact on its customers and suppliers and the range of governmental and community reactions to the pandemic, which are uncertain and cannot be fully predicted at this time.

New Accounting Pronouncements (

New Accounting Pronouncements (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The unaudited consolidated condensed financial statements included herein have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for interim financial information and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations. The information furnished in the consolidated condensed financial statements include all adjustments (consisting of only normal, recurring adjustments), considered necessary to present fairly the results of operations, financial position and cash flows of the Company. These financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2019. The operating results for interim periods are not necessarily indicative of results that may be expected for any other interim period or for the full year. In preparing these financial statements, management was required to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses. These estimates and assumptions are based on our historical experience, the terms of existing contracts, our evaluation of trends in the industry, information provided by our customers and suppliers and information available from other outside sources, as appropriate. These estimates and assumptions are subject to an inherent degree of uncertainty. We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates, judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained. As a result, actual results may differ significantly from our estimates, and any such differences may be material to our financial statements.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements Expected Credit Losses In June 2016, the Financial Accounting Standard Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments.” ASU 2016-13 requires measurement and recognition of expected credit losses for financial assets held. ASU 2016-13 is effective for annual and interim periods beginning after December 15, 2019. The Company adopted ASU 2016-13 as of January 1, 2020 and there was no significant impact on its consolidated condensed financial statements and related disclosures as a result. The Company considered the current and expected future economic and market conditions surrounding the COVID-19 pandemic and determined that the estimate of credit losses was not significantly impacted . Cloud Computing Arrangements That Are Service Contracts In August 2018, the FASB issued ASU 2018-15, “Intangibles – Goodwill and Other – Internal-Use Software (Subtopic 350-40): Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.” ASU 2018-15 requires implementation costs incurred by customers in cloud computing arrangements to be deferred and recognized over the term of the arrangement if those costs would be capitalized by the customer in a software licensing arrangement under the internal-use software guidance. ASU 2018-15 is effective for annual and interim periods beginning after December 15, 2019. The Company adopted ASU 2018-15 as of January 1, 2020 and there was no significant impact on its consolidated condensed financial statements and related disclosures as a result. Fair Value Measurement In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 removes certain disclosure requirements, including (i) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, (ii) the policy for timing of transfer between levels, and (iii) the valuation processes for Level 3 fair value measurements. ASU 2018-13 also adds new disclosure requirements, including (i) the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level 3 fair value measurements held at the end of the reporting period and (ii) the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. ASU 2018-13 is effective for annual and interim periods beginning after December 15, 2019. The Company adopted ASU 2018-13 as of January 1, 2020 and there was no significant impact on its consolidated condensed financial statements and related disclosures as a result.
Recently Issued Accounting Pronouncements Not Yet Adopted	Recently Issued Accounting Pronouncements Not Yet Adopted Retirement Benefits In August 2018, the FASB issued ASU 2018-14, “Compensation – Retirement Benefits – Defined Benefit Plans – General (Subtopic 715-20): Disclosure Framework – Changes to the Disclosure Requirements for Defined Benefit Plans.” ASU 2018-14 removes certain disclosure requirements, including (i) the amounts in accumulated other comprehensive income expected to be recognized as components of net periodic benefit cost over the next fiscal year, and (ii) the amount and timing of plan assets expected to be returned to the employer. ASU 2018-14 also adds new disclosure requirements, including (i) the weighted-average interest crediting rates for cash balance plans and other plans with promised interest crediting rates and (ii) an explanation of the reasons for significant gains and losses related to changes in the benefit obligation for the period. ASU 2018-14 is effective for annual periods ending after December 15, 2020. Early adoption of the amendments in this update is permitted. The Company is currently in the process of determining the impact the implementation of ASU 2018-14 will have on the Company’s financial statement note disclosures. Income Taxes In December 2019, the FASB issued Accounting Standard Update ASU No. 2019-12, "Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes". This ASU simplifies the accounting for income taxes by removing certain exceptions previously included in the guidance. In addition, the ASU provides new guidance on accounting for specific taxes and minor codification improvements.

Restructuring (Tables)

Restructuring (Tables)	3 Months Ended
	Mar. 31, 2020
Restructuring And Related Activities [Abstract]
Summary of Restructuring Expense by Reportable Segment	The following table summarizes restructuring expense for the three months ended March 31, 2020 and 2019 by reporting segment: Three Months Ended March 31, 2020 2019 Automotive $ 3,122 $ 368 Industrial 96 1,546 Reconciling items 548 — Total $ 3,766 $ 1,914
Summary of Restructuring Liability	The following table summarizes restructuring liability for the three months ended March 31, 2020: Employee Separation Costs Accelerated Depreciation Charges Other Related Costs Total Balance at December 31, 2019 $ 5,994 $ — $ 71 $ 6,065 Additions, charged to restructuring expenses 3,302 242 222 3,766 Cash payments (1,932 ) — (202 ) (2,134 ) Non-cash utilization — (242 ) — (242 ) Currency translation (306 ) — 38 (268 ) Balance at March 31, 2020 $ 7,058 $ — $ 129 $ 7,187

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings per Share and Weighted Average Shares Outstanding Used in Calculating Basic and Diluted Earnings per Share	The following table illustrates earnings per share and the weighted average shares outstanding used in calculating basic and diluted earnings per share: Three Months Ended March 31, 2020 2019 Net income $ 11,873 $ 8,414 Basic weighted average shares of Common Stock outstanding 32,692,895 33,573,411 Dilutive effect of stock options, restricted stock awards and restricted stock units 176,254 159,924 Diluted weighted average shares of Common Stock outstanding 32,869,149 33,733,335 Basic earnings per share $ 0.36 $ 0.25 Diluted earnings per share $ 0.36 $ 0.25
Common Stock Issuable upon Exercise of Certain Stock Options	The following table represents Common Stock issuable upon the exercise of certain stock options that have been excluded from the diluted earnings calculation because the effect of their inclusion would be anti-dilutive. Three Months Ended March 31, 2020 2019 Anti-dilutive securities share impact 682,741 396,500

Segment Reporting (Tables)

Segment Reporting (Tables)	3 Months Ended
	Mar. 31, 2020
Segment Reporting [Abstract]
Segment Information about Reported Product Revenues, Depreciation and Amortization and Operating Income (Loss)	The tables below present segment information about the reported product revenues, depreciation and amortization and operating income (loss) of the Company for three months ended March 31, 2020 and 2019. Three Months Ended March 31, Automotive Industrial Reconciling Items Consolidated Total 2020: Product revenues $ 216,472 $ 12,141 $ — $ 228,613 Depreciation and amortization 9,524 507 375 10,406 Operating income (loss) 31,706 (605 ) (12,400 ) 18,701 2019: Product revenues $ 242,357 $ 15,564 $ — $ 257,921 Depreciation and amortization 10,296 290 466 11,052 Operating income (loss) 39,896 (4,514 ) (13,537 ) 21,845
Segment Information About Reported Segment Product Revenues by Product Category	Automotive and Industrial segment product revenues by product category for the three months ended March 31, 2020 and 2019 were as follows: Three Months Ended March 31, 2020 2019 Climate Control Seats (CCS) $ 82,528 $ 94,354 Seat Heaters 64,532 73,920 Automotive Cables 22,140 23,749 Steering Wheel Heaters 19,235 16,970 Battery Thermal Management (BTM) 11,209 10,745 Electronics 10,376 12,852 Other Automotive 6,452 9,767 Subtotal Automotive 216,472 242,357 Medical 12,141 8,187 GPT — 3,959 CSZ-IC — 3,418 Subtotal Industrial 12,141 15,564 Total Company $ 228,613 $ 257,921
Product Revenues Information by Geographic Area	Total product revenues information by geographic area is as follows (based on shipment destination): Three Months Ended March 31, 2020 2019 United States $ 105,918 $ 118,454 Germany 16,830 23,210 South Korea 16,417 14,978 Japan 16,137 18,591 China 13,003 15,597 Czech Republic 10,073 12,142 Canada 8,262 10,291 Romania 7,659 6,922 United Kingdom 6,964 8,832 Other 27,350 28,904 Total Non-U.S. $ 122,695 $ 139,467 Total Company $ 228,613 $ 257,921

Revenue Recognition (Tables)

Revenue Recognition (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue Recognition And Deferred Revenue [Abstract]
Schedule of Changes in Unearned Revenue Balance	Changes in the unearned revenue balance during the three months ended March 31, 2020 were as follows: Balance as of December 31, 2019 $ 579 Additions to unearned revenue — Reclassified to revenue (389 ) Currency impacts (4 ) Balance as of March 31, 2020 $ 186

Income Taxes (Tables)

Income Taxes (Tables)	3 Months Ended
	Mar. 31, 2020
Income Tax Disclosure [Abstract]
Summary of Provision for Income Taxes and Corresponding Effective Tax Rate	A summary of the provision for income taxes and the corresponding effective tax rate for the three months ended March 31, 2020 and 2019, is shown below: Three Months Ended March 31, 2020 2019 Income tax expense $ 5,406 $ 6,895 Earnings before income tax $ 17,279 $ 15,309 Effective tax rate 31.3 % 45.0 % Income tax expense $ 5,406 $ 6,895 Earnings before income tax excluding impairment loss $ 17,279 $ 25,793 Effective tax rate excluding impairment loss 31.3 % 26.7 %

Details of Certain Balance Sh_2

Details of Certain Balance Sheet Components (Tables)	3 Months Ended
	Mar. 31, 2020
Balance Sheet Components [Abstract]
Summary of Certain Balance Sheet Components	March 31, 2020 December 31, 2019 Other current assets: Income tax and other tax receivable $ 16,648 $ 17,057 Notes receivable 9,308 9,963 Prepaid expenses 9,027 7,022 Billable tooling 5,471 5,194 Short-term derivative financial instruments — 1,242 Other 4,487 2,248 Total other current assets $ 44,941 $ 42,726 Other current liabilities: Liabilities from discounts and rebates $ 18,877 $ 16,593 Accrued employee liabilities 16,150 26,019 Restructuring 7,187 6,065 Income and other taxes payable 5,644 3,693 Derivative financial instruments 3,553 — Accrued warranty 3,323 4,596 Other 12,266 9,617 Total other current liabilities $ 67,000 $ 66,583

Goodwill and Other Intangibles

Goodwill and Other Intangibles (Tables)	3 Months Ended
	Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Summary of Changes in the Carrying Amount of Goodwill, By Operating Segment	A summary of changes in the carrying amount of goodwill, by operating segment, for the three months ended March 31, 2020 is as follows: Automotive Industrial Total Balance as of December 31, 2019 $ 36,938 $ 27,634 $ 64,572 Exchange rate impact (502 ) (176 ) (678 ) Balance as of March 31, 2020 $ 36,436 $ 27,458 $ 63,894
Summary of Other Intangible Assets and Accumulated Amortization Balances	Other intangible assets and accumulated amortization balances as of March 31, 2020 and December 31, 2019 were as follows: Gross Carrying Value Accumulated Amortization Net Carrying Value Definite-lived: Customer relationships $ 87,519 $ (51,181 ) $ 36,338 Technology 27,782 (19,943 ) 7,839 Product development costs 19,455 (18,240 ) 1,215 Indefinite-lived: Tradenames 4,670 — 4,670 Balance as of March 31, 2020 $ 139,426 $ (89,364 ) $ 50,062 Gross Carrying Value Accumulated Amortization Net Carrying Value Definite-lived: Customer relationships $ 89,208 $ (50,687 ) $ 38,521 Technology 25,106 (19,866 ) 5,240 Product development costs 19,911 (18,559 ) 1,352 Indefinite-lived: Tradenames 4,670 — 4,670 Balance as of December 31, 2019 $ 138,895 $ (89,112 ) $ 49,783

Debt (Tables)

Debt (Tables)	3 Months Ended
	Mar. 31, 2020
Debt Disclosure [Abstract]
Summary of Company's Debt	The following table summarizes the Company’s debt as of March 31, 2020 and December 31, 2019: March 31, 2020 December 31, 2019 Interest Rate Principal Balance Interest Rate Principal Balance Amended Credit Agreement: U.S. Revolving Note (U.S. Dollar Denominations) 2.20 % $ 183,000 3.05 % $ 50,000 U.S. Revolving Note (Euro Denominations) 1.25 % 42,417 1.25 % 21,874 DEG Vietnam Loan 5.21 % 8,750 5.21 % 8,750 Total debt 234,167 80,624 Less: current maturities (2,500 ) (2,500 ) Long-term debt, less current maturities $ 231,667 $ 78,124
Principal Maturities of Debt	The scheduled principal maturities of our debt as of March 31, 2020 were as follows: Year U.S. Revolving Note DEG Vietnam Note Total Remainder of 2020 $ — $ 2,500 $ 2,500 2021 — 2,500 2,500 2022 — 2,500 2,500 2023 — 1,250 1,250 2024 225,417 — 225,417 Total $ 225,417 $ 8,750 $ 234,167

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Components of Lease Expense and Other Information	Components of lease expense for the three months ended March 31, 2020 were as follows: Three Months Ended March 31, 2020 Lease cost: Operating lease cost $ 1,586 Short-term lease cost 509 Sublease income (40 ) Total lease cost $ 2,055 Other information related to leases is as follows: Three Months Ended March 31, 2020 Cash paid for amounts included in the measurement of lease liabilities: Operating cash flows for operating leases $ 1,621 Right-of-use lease assets obtained in exchange for lease obligations: Operating leases $ 6,349 March 31, 2020 Weighted average remaining lease term: Operating leases 6.5 years Weighted average discount rate: Operating leases 5.08 %
Summary of Operating Leases Under all Non-Cancellable Operating Leases	A summary of operating leases as of March 31, 2020, under all non-cancellable operating leases with terms exceeding one year is as follows: 2020 (excluding the three months ended March 31, 2020) $ 4,252 2021 4,153 2022 1,997 2023 1,256 2024 1,258 2025 or later 5,468 Total future minimum lease payments 18,384 Less imputed interest (2,780 ) Total $ 15,604

Financial Instruments (Tables)

Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments And Hedging Activities Disclosure [Abstract]
Reconciliation of Cash and Cash Equivalents and Restricted Cash	A reconciliation of cash and cash equivalents on the consolidated condensed balance sheets to cash, cash equivalents and restricted cash presented on the consolidated condensed statements of cash flows is as follows: March 31, 2020 December 31, 2019 Cash and cash equivalents presented in the consolidated condensed balance sheets $ 222,939 $ 50,443 Restricted cash 2,505 2,505 Cash, cash equivalents and restricted cash presented in the consolidated condensed statements of cash flows $ 225,444 $ 52,948
Information Related to Recurring Fair Value Measurement of Derivative Instruments in Our Consolidated Condensed Balance Sheet	Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of March 31, 2020 is as follows: Asset Derivatives Liability Derivatives Hedge Designation Fair Value Hierarchy Balance Sheet Location Fair Value Balance Sheet Location Fair Value Net Asset/ (Liabilities) Foreign currency derivatives Cash flow hedge Level 2 Other current assets $ — Other current liabilities $ (3,553 ) $ (3,553 ) Information related to the recurring fair value measurement of derivative instruments in our consolidated condensed balance sheet as of December 31, 2019 is as follows: Asset Derivatives Liability Derivatives Hedge Designation Fair Value Hierarchy Balance Sheet Location Fair Value Balance Sheet Location Fair Value Net Asset/ (Liabilities) Foreign currency derivatives Cash flow hedge Level 2 Other current assets $ 1,242 Other current liabilities $ — $ 1,242
Information Related to Effect of Derivative Instruments on Our Consolidated Condensed Statements of Income	Information relating to the effect of derivative instruments on our consolidated condensed statements of income is as follows: Three Months Ended March 31, Location 2020 2019 Foreign currency derivatives Cost of sales $ 78 $ 240 Other comprehensive (loss) income (4,795 ) 766 Foreign currency loss (71 ) (37 ) Total foreign currency derivatives $ (4,788 ) $ 969

Reclassifications Out of Accu_2

Reclassifications Out of Accumulated Other Comprehensive Loss (Tables)	3 Months Ended
	Mar. 31, 2020
Equity [Abstract]
Schedule of Reclassification Adjustments and Other Activities Impacting Accumulated Other Comprehensive Income (Loss)	Reclassification adjustments and other activities impacting accumulated other comprehensive income (loss) during the three months ended March 31, 2020 and March 31, 2019 were as follows: Defined Benefit Pension Plans Foreign Currency Translation Adjustments Foreign Currency Hedge Derivatives Total Balance at December 31, 2019 $ (3,371 ) $ (39,965 ) $ 895 $ (42,441 ) Other comprehensive loss before reclassifications — (8,687 ) (4,170 ) (12,857 ) Income tax effect of other comprehensive (loss) income before reclassifications — (53 ) 909 856 Amounts reclassified from accumulated other comprehensive loss into net income — — (625 ) a (625 ) Income taxes reclassified into net income — — 136 136 Net current period other comprehensive loss — (8,740 ) (3,750 ) (12,490 ) Balance at March 31, 2020 $ (3,371 ) $ (48,705 ) $ (2,855 ) $ (54,931 ) (a) The amounts reclassified from accumulated other comprehensive income (loss) were included in cost of sales. Defined Benefit Pension Plans Foreign Currency Translation Adjustments Foreign Currency Hedge Derivatives Total Balance at December 31, 2018 $ (2,339 ) $ (37,157 ) $ (4 ) $ (39,500 ) Other comprehensive income (loss) before reclassifications — (4,074 ) 717 (3,357 ) Income tax effect of other comprehensive loss before reclassifications — (177 ) (156 ) (333 ) Amounts reclassified from accumulated other comprehensive loss into net income — — 49 a 49 Income taxes reclassified into net income — — (11 ) (11 ) Net current period other comprehensive (loss) income — (4,251 ) 599 (3,652 ) Balance at March 31, 2019 $ (2,339 ) $ (41,408 ) $ 595 $ (43,152 ) (a) The amounts reclassified from accumulated other comprehensive income (loss) were included in cost of sales.

Commitments and Contingencies (

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2020
Commitments And Contingencies Disclosure [Abstract]
Reconciliation of Changes in Accrued Warranty Costs	The following is a reconciliation of the changes in accrued warranty costs: Three Months Ended March 31, 2020 2019 Balance at beginning of the period $ 4,596 $ 4,514 Warranty claims paid (1,278 ) (276 ) Warranty expense for products shipped during the period 500 709 Adjustments to warranty estimates from prior periods (450 ) (305 ) Adjustments due to currency translation (45 ) (26 ) Balance at end of period $ 3,323 $ 4,616

Acquisitions and Divestitures -

Acquisitions and Divestitures - Additional Information (Detail) - USD ($) $ in Thousands	Apr. 01, 2019	Feb. 01, 2019	Mar. 31, 2019
Business Acquisition [Line Items]
Pre-tax gain (loss) on sale of business			$ 4,970
Asset impairment charges			10,484
GPT
Business Acquisition [Line Items]
Asset impairment charges			6,998
Impairment on assets held for sale			3,486
CSZ-IC
Business Acquisition [Line Items]
Total cash proceeds		$ 47,500
Escrow deposit		$ 2,500
Pre-tax gain (loss) on sale of business			$ 4,970
Stihler Electronic GmbH
Business Acquisition [Line Items]
Net assets acquired	$ 15,476
Business combination future contingent consideration milestone payment	$ 653

Restructuring - Additional Info

Restructuring - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	$ 3,766,000	$ 1,914,000
Impairment loss		10,484,000
Manufacturing Footprint Rationalization | Minimum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	20,000,000
Manufacturing Footprint Rationalization | Maximum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	24,000,000
Advanced Research and Development Rationalization and Site Consolidation
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	7,440,000
Other Restructuring Activities
Restructuring Cost And Reserve [Line Items]
Impairment loss		425,000
GPT and CSZ-IC
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	2,303,000
Employee Separation Costs
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	3,302,000
Employee Separation Costs | Manufacturing Footprint Rationalization
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	248,000
Restructuring reserve accelerated depreciation	242,000
Employee Separation Costs | Manufacturing Footprint Rationalization | Minimum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	9,000,000
Employee Separation Costs | Manufacturing Footprint Rationalization | Maximum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	11,000,000
Employee Separation Costs | Other Restructuring Activities
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	3,054,000	395,000
Employee Separation Costs | GPT and CSZ-IC
Restructuring Cost And Reserve [Line Items]
Restructuring expenses		251,000
Cash Expenditures | Manufacturing Footprint Rationalization | Minimum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	17,000,000
Cash Expenditures | Manufacturing Footprint Rationalization | Maximum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	21,000,000
Restructuring Capital Expenditures | Manufacturing Footprint Rationalization | Minimum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	4,500,000
Restructuring Capital Expenditures | Manufacturing Footprint Rationalization | Maximum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	5,500,000
Accelerated Depreciation and Impairment | Manufacturing Footprint Rationalization
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	3,000,000
Other Restructuring
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	222,000
Other Restructuring | Manufacturing Footprint Rationalization | Minimum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	3,500,000
Other Restructuring | Manufacturing Footprint Rationalization | Maximum
Restructuring Cost And Reserve [Line Items]
Restructuring and related cost expected total cost	4,500,000
Other Restructuring | Other Restructuring Activities
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	$ 222,000	4,000
Other Restructuring | GPT and CSZ-IC
Restructuring Cost And Reserve [Line Items]
Restructuring expenses		$ 839,000

Restructuring - Summary of Rest

Restructuring - Summary of Restructuring Expense by Reportable Segment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	$ 3,766	$ 1,914
Operating Segments | Automotive Segments
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	3,122	368
Operating Segments | Industrial Segments
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	96	$ 1,546
Reconciling Items
Restructuring Cost And Reserve [Line Items]
Restructuring expenses	$ 548

Restructuring - Summary of Re_2

Restructuring - Summary of Restructuring Liability (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Restructuring Cost And Reserve [Line Items]
Balance, beginning of period	$ 6,065
Additions, charged to restructuring expenses	3,766	$ 1,914
Cash payments	(2,134)
Non-cash utilization	(242)
Currency translation	(268)
Balance, end of period	7,187
Employee Separation Costs
Restructuring Cost And Reserve [Line Items]
Balance, beginning of period	5,994
Additions, charged to restructuring expenses	3,302
Cash payments	(1,932)
Currency translation	(306)
Balance, end of period	7,058
Accelerated Depreciation Charges
Restructuring Cost And Reserve [Line Items]
Additions, charged to restructuring expenses	242
Non-cash utilization	(242)
Other Restructuring
Restructuring Cost And Reserve [Line Items]
Balance, beginning of period	71
Additions, charged to restructuring expenses	222
Cash payments	(202)
Currency translation	38
Balance, end of period	$ 129

Earnings Per Share (Detail)

Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Net income	$ 11,873	$ 8,414
Basic weighted average shares of Common Stock outstanding	32,692,895	33,573,411
Dilutive effect of stock options, restricted stock awards and restricted stock units	176,254	159,924
Diluted weighted average shares of Common Stock outstanding	32,869,149	33,733,335
Basic earnings per share	$ 0.36	$ 0.25
Diluted earnings per share	$ 0.36	$ 0.25
Anti-dilutive securities share impact	682,741	396,500

Segment Reporting - Segment Inf

Segment Reporting - Segment Information about Reported Product Revenues, Depreciation and Amortization and Operating Income (Loss) (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Product revenues	$ 228,613	$ 257,921
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Depreciation and amortization	$ 10,406	$ 11,052
Operating income (loss)	18,701	21,845
Automotive Segments
Segment Reporting Information [Line Items]
Product revenues	216,472	242,357
Industrial Segments
Segment Reporting Information [Line Items]
Product revenues	12,141	15,564
Operating Segments | Automotive Segments
Segment Reporting Information [Line Items]
Product revenues	$ 216,472	$ 242,357
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Depreciation and amortization	$ 9,524	$ 10,296
Operating income (loss)	31,706	39,896
Operating Segments | Industrial Segments
Segment Reporting Information [Line Items]
Product revenues	$ 12,141	$ 15,564
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Depreciation and amortization	$ 507	$ 290
Operating income (loss)	$ (605)	$ (4,514)
Reconciling Items
Segment Reporting Information [Line Items]
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
Depreciation and amortization	$ 375	$ 466
Operating income (loss)	$ (12,400)	$ (13,537)

Segment Reporting - Segment I_2

Segment Reporting - Segment Information About Reported Segment Product Revenues by Product Category (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Product revenues	$ 228,613	$ 257,921
Automotive Segments
Segment Reporting Information [Line Items]
Product revenues	216,472	242,357
Automotive Segments | Climate Control Seats (CCS)
Segment Reporting Information [Line Items]
Product revenues	82,528	94,354
Automotive Segments | Seat Heaters
Segment Reporting Information [Line Items]
Product revenues	64,532	73,920
Automotive Segments | Automotive Cables
Segment Reporting Information [Line Items]
Product revenues	22,140	23,749
Automotive Segments | Steering Wheel Heaters
Segment Reporting Information [Line Items]
Product revenues	19,235	16,970
Automotive Segments | Battery Thermal Management (BTM)
Segment Reporting Information [Line Items]
Product revenues	11,209	10,745
Automotive Segments | Electronics
Segment Reporting Information [Line Items]
Product revenues	10,376	12,852
Automotive Segments | Other Automotive
Segment Reporting Information [Line Items]
Product revenues	6,452	9,767
Industrial Segments
Segment Reporting Information [Line Items]
Product revenues	12,141	15,564
Industrial Segments | Medical
Segment Reporting Information [Line Items]
Product revenues	$ 12,141	8,187
Industrial Segments | GPT
Segment Reporting Information [Line Items]
Product revenues		3,959
Industrial Segments | CSZ-IC
Segment Reporting Information [Line Items]
Product revenues		$ 3,418

Segment Reporting (Detail)

Segment Reporting (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Segment Reporting Information [Line Items]
Product revenues	$ 228,613	$ 257,921
Type of Revenue [Extensible List]	us-gaap:ProductMember	us-gaap:ProductMember
United States
Segment Reporting Information [Line Items]
Product revenues	$ 105,918	$ 118,454
Germany
Segment Reporting Information [Line Items]
Product revenues	16,830	23,210
South Korea
Segment Reporting Information [Line Items]
Product revenues	16,417	14,978
Japan
Segment Reporting Information [Line Items]
Product revenues	16,137	18,591
China
Segment Reporting Information [Line Items]
Product revenues	13,003	15,597
Czech Republic
Segment Reporting Information [Line Items]
Product revenues	10,073	12,142
Canada
Segment Reporting Information [Line Items]
Product revenues	8,262	10,291
Romania
Segment Reporting Information [Line Items]
Product revenues	7,659	6,922
United Kingdom
Segment Reporting Information [Line Items]
Product revenues	6,964	8,832
Other
Segment Reporting Information [Line Items]
Product revenues	27,350	28,904
Non U.S.
Segment Reporting Information [Line Items]
Product revenues	$ 122,695	$ 139,467

Revenue Recognition - Additiona

Revenue Recognition - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Revenue Recognition And Deferred Revenue [Abstract]
Aggregate amount of transaction price allocated to material rights that remain unsatisfied	$ 186
Revenue expected to be recognized remainder of 2020	23.00%
Revenue expected to be recognized in 2021	28.00%
Revenue expected to be recognized in 2022	27.00%
Revenue expected to be recognized in 2023	22.00%
Expected period of costs to be realized to recognize assets	1 year
capitalized costs to obtain contract	$ 1,800	$ 1,893

Schedule of Changes in Unearned

Schedule of Changes in Unearned Revenue Balance (Detail) - Automotive Segment $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Deferred Revenue Arrangement [Line Items]
Beginning balance	$ 579
Reclassified to revenue	(389)
Currency impacts	(4)
Ending balance	$ 186

Income Taxes - Summary of Provi

Income Taxes - Summary of Provision for Income Taxes and Corresponding Effective Tax Rate (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Tax Disclosure [Abstract]
Income tax expense	$ 5,406	$ 6,895
Earnings before income tax	$ 17,279	$ 15,309
Effective tax rate	31.30%	45.00%
Earnings before income tax excluding impairment loss	$ 17,279	$ 25,793
Effective tax rate excluding impairment loss	31.30%	26.70%

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2019USD ($)
Income Tax Disclosure [Abstract]
Impairment loss	$ 10,484

Details of Certain Balance Sh_3

Details of Certain Balance Sheet Components (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Current Assets:
Income tax and other tax receivable	$ 16,648	$ 17,057
Notes receivable	9,308	9,963
Prepaid expenses	9,027	7,022
Billable tooling	5,471	5,194
Short-term derivative financial instruments		1,242
Other	4,487	2,248
Total other current assets	44,941	42,726
Other current liabilities:
Liabilities from discounts and rebates	18,877	16,593
Accrued employee liabilities	16,150	26,019
Restructuring	7,187	6,065
Income and other taxes payable	5,644	3,693
Derivative financial instruments	3,553
Accrued warranty	3,323	4,596	$ 4,616	$ 4,514
Other	12,266	9,617
Total other current liabilities	$ 67,000	$ 66,583

Goodwill and Other Intangible_2

Goodwill and Other Intangibles - Summary of Changes in the Carrying Amount of Goodwill, By Operating Segment (Detail) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Goodwill [Line Items]
Balance, beginning of period	$ 64,572
Balance, end of period	63,894
Operating Segments
Goodwill [Line Items]
Balance, beginning of period	64,572
Exchange rate impact	(678)
Balance, end of period	63,894
Automotive Segments | Operating Segments
Goodwill [Line Items]
Balance, beginning of period	36,938
Exchange rate impact	(502)
Balance, end of period	36,436
Industrial Segments
Goodwill [Line Items]
Balance, beginning of period	27,634
Exchange rate impact	(176)
Balance, end of period	$ 27,458

Goodwill and Other Intangible_3

Goodwill and Other Intangibles - Summary of Other Intangible Assets and Accumulated Amortization Balances (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019
Intangible Assets [Line Items]
Gross Carrying Value	$ 139,426		$ 138,895
Accumulated Amortization	(89,364)		(89,112)
Net Carrying Value	50,062	$ 49,783
Net Carrying Value	50,062		49,783
Customer Relationships
Intangible Assets [Line Items]
Gross Carrying Value	87,519		89,208
Accumulated Amortization	(51,181)		(50,687)
Net Carrying Value	36,338		38,521
Technology
Intangible Assets [Line Items]
Gross Carrying Value	27,782		25,106
Accumulated Amortization	(19,943)		(19,866)
Net Carrying Value	7,839		5,240
Product Development Costs
Intangible Assets [Line Items]
Gross Carrying Value	19,455		19,911
Accumulated Amortization	(18,240)		(18,559)
Net Carrying Value	1,215		1,352
Tradenames
Intangible Assets [Line Items]
Net Carrying Value	$ 4,670		$ 4,670

Goodwill and Other Intangible_4

Goodwill and Other Intangibles - Additional Information (Detail) - Development Stage Technology Company $ in Thousands	Feb. 28, 2020USD ($)
Goodwill And Other Intangible Assets [Line Items]
Automotive patents and technology acquired	$ 3,141
Defensive intangible assets, useful life	6 years

Summary of Company's Debt (Deta

Summary of Company's Debt (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Total debt	$ 234,167	$ 80,624
Less: current maturities	(2,500)	(2,500)
Long-term debt, less current maturities	$ 231,667	$ 78,124
U.S. Revolving Note (U.S. Dollar Denominations)
Debt Instrument [Line Items]
Interest Rate	2.20%	3.05%
Total debt	$ 183,000	$ 50,000
U.S. Revolving Note (Euro Denominations)
Debt Instrument [Line Items]
Interest Rate	1.25%	1.25%
Total debt	$ 42,417	$ 21,874
DEG Vietnam Loan
Debt Instrument [Line Items]
Interest Rate	5.21%	5.21%
Total debt	$ 8,750	$ 8,750

Debt - Additional Information (

Debt - Additional Information (Detail) - USD ($)	Jun. 27, 2019	Jun. 26, 2019	Mar. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Maximum percentage of stock of non US subsidiaries pledge to secure obligation			66.00%
Federal Funds Rate | Minimum
Debt Instrument [Line Items]
Interest rate			0.50%
Federal Funds Rate | Maximum
Debt Instrument [Line Items]
Interest rate			0.08%
London Interbank Offered Rate
Debt Instrument [Line Items]
Interest rate			0.99%
United State Bank Of America Credit Facility
Debt Instrument [Line Items]
Interest rate			3.25%
Euro Currency Rate Loans
Debt Instrument [Line Items]
Interest rate			1.00%
Euro Currency Rate Loans | Credit Agreement | Minimum
Debt Instrument [Line Items]
Interest rate			1.25%
Euro Currency Rate Loans | Credit Agreement | Maximum
Debt Instrument [Line Items]
Interest rate			2.25%
Base Rate Loans | Credit Agreement | Minimum
Debt Instrument [Line Items]
Interest rate			0.25%
Base Rate Loans | Credit Agreement | Maximum
Debt Instrument [Line Items]
Interest rate			1.25%
DEG Vietnam Loan
Debt Instrument [Line Items]
Semi-annual principal payments earliest date			2017-11
Semi-annual principal payments latest date			2023-05
Revolving Credit Facility | Revolving Note (U.S. Dollar)
Debt Instrument [Line Items]
Maximum borrowing capacity	$ 475,000,000	$ 350,000,000			$ 350,000,000
Maximum borrowing capacity increase subject to specified conditions			$ 175,000,000
Line of credit, outstanding amount			225,417,000
Debt maturity date	Jun. 27, 2024	Mar. 17, 2021
Increase in maximum borrowing capacity			169,546,000
Remaining borrowing capacity			226,743,000
Revolving Credit Facility | Revolving Note (U.S. Dollar) | Letters of Credit
Debt Instrument [Line Items]
Maximum borrowing capacity			15,000,000
Line of credit, outstanding amount			0	$ 0
Revolving Credit Facility | Revolving Note (U.S. Dollar) | Swing Line Loans
Debt Instrument [Line Items]
Maximum borrowing capacity			$ 40,000,000

Principal Maturities of Debt (D

Principal Maturities of Debt (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt Instrument [Line Items]
Debt maturing in remainder of 2020	$ 2,500
Debt maturing in 2021	2,500
Debt maturing in 2022	2,500
Debt maturing in 2023	1,250
Debt maturing in 2024	225,417
Total debt	234,167	$ 80,624
US and Euro Denominated Revolving Note
Debt Instrument [Line Items]
Debt maturing in 2024	225,417
Total debt	225,417
DEG Vietnam Loan
Debt Instrument [Line Items]
Debt maturing in remainder of 2020	2,500
Debt maturing in 2021	2,500
Debt maturing in 2022	2,500
Debt maturing in 2023	1,250
Total debt	$ 8,750	$ 8,750

Leases - Additional Information

Leases - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2020
Lessee Lease Description [Line Items]
Operating lease, description	The Company has operating leases for office, manufacturing and research and development facilities, as well as land leases for certain manufacturing facilities that are accounted for as operating leases. The Company also has operating leases for office equipment and automobiles.
Operating lease, existence of option to extend	true
Operating lease, options to extend	Excluding land leases, our leases have remaining lease terms ranging from less than 1 year to 12 years and may include options to extend the lease for an additional term equal to the original term of the lease.
Minimum
Lessee Lease Description [Line Items]
Operating lease, term of contract	1 year
Minimum | Ground
Lessee Lease Description [Line Items]
Operating lease, term of contract	41 years
Maximum
Lessee Lease Description [Line Items]
Operating lease, term of contract	12 years
Maximum | Ground
Lessee Lease Description [Line Items]
Operating lease, term of contract	43 years

Leases - Components of Lease Ex

Leases - Components of Lease Expense, Weighted-Average Remaining Lease Term and Discount Rate and Other Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)
Lease cost:
Operating lease cost	$ 1,586
Short-term lease cost	509
Sublease income	(40)
Total lease cost	2,055
Operating cash flows for operating leases	1,621
Right-of-use lease assets obtained in exchange for lease obligations, Operating leases	$ 6,349
Weighted Average Remaining Lease Term, Operating leases	6 years 6 months
Weighted Average Discount Rate, Operating leases	5.08%

Leases - Summary of Operating L

Leases - Summary of Operating Leases Under all Non-Cancellable Operating Leases (Detail) $ in Thousands	Sep. 30, 2019USD ($)
Leases [Abstract]
2020 (excluding the three months ended March 31, 2020)	$ 4,252
2021	4,153
2022	1,997
2023	1,256
2024	1,258
2025 or later	5,468
Total future minimum lease payments	18,384
Less imputed interest	(2,780)
Total	$ 15,604

Reconciliation of Cash and Cash

Reconciliation of Cash and Cash Equivalents and Restricted Cash (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Accounting Policies [Abstract]
Cash and cash equivalents presented in the consolidated condensed balance sheets	$ 222,939	$ 50,443
Restricted cash	2,505	2,505
Cash, cash equivalents and restricted cash presented in the consolidated condensed statements of cash flows	$ 225,444	$ 52,948	$ 41,269	$ 39,620

Financial Instruments - Additio

Financial Instruments - Additional Information (Detail) - USD ($)	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Derivative [Line Items]
Maximum length of time to hedges exposure to foreign currency exchange risk	1 year
Foreign Currency Derivatives
Derivative [Line Items]
Notional Value	$ 22,176,000		$ 14,449,000
Interest Rate Swap
Derivative [Line Items]
Hedge Ineffectiveness Incurred	$ 0	$ 0

Information Related to Recurrin

Information Related to Recurring Fair Value Measurement of Derivative Instruments in Our Consolidated Condensed Balance Sheet (Detail) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Derivatives Fair Value [Line Items]
Net Asset/ (Liabilities)		$ 1,242
Fair Value, Inputs, Level 2 | Foreign Currency Derivatives | Designated as Hedging Instrument
Derivatives Fair Value [Line Items]
Net Asset/ (Liabilities)	$ (3,553)	1,242
Fair Value, Inputs, Level 2 | Foreign Currency Derivatives | Other Current Assets | Designated as Hedging Instrument
Derivatives Fair Value [Line Items]
Asset Derivatives, Fair Value		$ 1,242
Fair Value, Inputs, Level 2 | Foreign Currency Derivatives | Other Current Liabilities | Designated as Hedging Instrument
Derivatives Fair Value [Line Items]
Liability Derivatives, Fair Value	$ (3,553)

Information Related to Effect o

Information Related to Effect of Derivative Instruments on Our Consolidated Condensed Statements of Income (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	$ (4,788)	$ 969
Other comprehensive (loss) income | Foreign Currency Derivatives
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	(4,795)	766
Cost of sales | Foreign Currency Derivatives
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	78	240
Foreign currency loss | Foreign Currency Derivatives
Derivative Instruments Gain Loss [Line Items]
Gain (loss) on derivatives	$ (71)	$ (37)

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Detail) - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Carrying value	$ 234,167,000	$ 80,624,000
Fair Value, Recurring Basis
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Financial assets, fair value	0	0
Financial liabilities, fair value	0	0
Fair Value, Nonrecurring Basis
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Financial assets, fair value	0	0
Financial liabilities, fair value	0	0
DEG Vietnam Loan
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Carrying value	8,750,000	8,750,000
Fair value	$ 9,063,000	$ 8,785,000

Equity - Additional Information

Equity - Additional Information (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	1 Months Ended		3 Months Ended
	Jun. 30, 2018	Dec. 31, 2016	Mar. 31, 2020
Equity [Abstract]
Stock repurchase program period		3 years
Stock repurchase program, authorized amount		$ 100
Authorized increase and extension in stock repurchase program amount	$ 300
Stock repurchase program extended expiration date	2020-12
Shares repurchased			9.1
Shares repurchased average price paid per share			$ 36.93
Remaining authorized repurchase amount			$ 74.2

Schedule of Reclassification Ad

Schedule of Reclassification Adjustments and Other Activities Impacting Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Thousands		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance		$ (42,441)	$ (39,500)
Other comprehensive income (loss) before reclassifications		(12,857)	(3,357)
Income tax effect of other comprehensive (loss) income before reclassifications		856	(333)
Amounts reclassified from accumulated other comprehensive loss into net income		(625)	49
Income taxes reclassified into net income		136	(11)
Other comprehensive loss, net of tax		(12,490)	(3,652)
Ending Balance		(54,931)	(43,152)
Defined Benefit Pension Plans
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance		(3,371)	(2,339)
Ending Balance		(3,371)	(2,339)
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance		(39,965)	(37,157)
Other comprehensive income (loss) before reclassifications		(8,687)	(4,074)
Income tax effect of other comprehensive (loss) income before reclassifications		(53)	(177)
Other comprehensive loss, net of tax		(8,740)	(4,251)
Ending Balance		(48,705)	(41,408)
Foreign Currency Hedge Derivatives
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning Balance		895	(4)
Other comprehensive income (loss) before reclassifications		(4,170)	717
Income tax effect of other comprehensive (loss) income before reclassifications		909	(156)
Amounts reclassified from accumulated other comprehensive loss into net income	[1]	(625)	49
Income taxes reclassified into net income		136	(11)
Other comprehensive loss, net of tax		(3,750)	599
Ending Balance		$ (2,855)	$ 595
[1]	The amounts reclassified from accumulated other comprehensive income (loss) were included in cost of sales.

Commitments and Contingencies -

Commitments and Contingencies - Reconciliation of Changes in Accrued Warranty Costs (Detail) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Loss Contingency [Abstract]
Balance at beginning of the period	$ 4,596	$ 4,514
Warranty claims paid	(1,278)	(276)
Warranty expense for products shipped during the period	500	709
Adjustments to warranty estimates from prior periods	(450)	(305)
Adjustments due to currency translation	(45)	(26)
Balance at end of period	$ 3,323	$ 4,616